Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0VR7F
|
|||
Drug Name |
CNTX-6970
|
|||
Indication | Inflammatory pain [ICD-11: MG30.42; ICD-10: R52, G89] | Phase 1 | [1] | |
Company |
Centrexion Therapeutics Boston, MA
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | C-C chemokine receptor type 2 (CCR2) | Target Info | Antagonist | [1] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | ||||
Leptin Signaling Pathway | ||||
RANKL Signaling Pathway | ||||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
Reactome | Beta defensins | |||
Chemokine receptors bind chemokines | ||||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Defensins | ||||
Spinal Cord Injury | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.